OAOmar Afroz

Omar Afroz

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Omar Afroz has a total of 21 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Wearable health trackers: A potential candidate for behavioural addiction?

    by Raja Babu Ramawat, Omar Afroz, Siddharth Sarkar

    Wearable health trackers are a type of health and fitness self-service technology that is becoming increasingly popular. Effective monitoring of health parameters offered through these devices helps in planning physical activity and weight reduction, with studies reporting their use in rehabilitation for chronic medical illnesses. However, the potential risks and harms associated with these devices remain underexplored. Apart from physical risks, such as increased risk of accidents, psychological issues related to the use of these devices include stress, guilt, low mood, and health anxiety. When criteria for behavioural addiction are applied to the use of these devices, the criteria of clinical relevance and phenomenology of use appear to be partly met, while there is a lack of data on theoretical understanding or taxonomic plausibility. We suggest that these devices be considered as a potential candidate for research on behavioural addiction. At the same time, we argue against overmedicalizing behaviours without evidence and call for a balanced approach in research to determine both the benefits and potential harms associated with wearable health trackers.


  • Scabies and psychiatric comorbidity: Beyond the itch

    by Omar Afroz, Raja Babu Ramawat

    Scabies is a neglected tropical disease affecting 12% of the population globally, with a rise in incidence in many countries. It presents with intense itching, more intense nocturnally. Untreated complications such as secondary bacterial infections and systemic illnesses may ensue. However, its impact on mental health is relatively understudied. Most studies have focused on the assessment of the quality of life, with limited research on psychiatric illnesses. Clinicians in dermatology settings should be aware of the possibility of comorbid psychiatric illnesses in scabies patients and consider brief screening and timely referrals for psychiatric care. Psychiatric patients may be vulnerable to scabies infestation, and mental health professionals should assess for scabies in psychiatric patients presenting with pruritus.


  • Open Access

    A Comparative Study of Sociodemographic, Clinical, and Psychosocial Parameters Between Injecting and Non-injecting Opioid-dependent Males

    by Imamuddin Khan, Sonali Jhanjee, Anju Dhawan, Omar Afroz

    Background: Opioid use disorder (OUD), particularly injection drug use (IDU), is on the rise and is associated with complications such as blood-borne infections, overdosing, and seizures, among others. Understanding factors distinguishing non-injecting opioid users (NIOU) and IDUs is essential for the development of effective prevention and management strategies. This study aimed to compare sociodemographic, clinical, and psychosocial factors between IDUs and NIOUs. Methods: A cross-sectional study was conducted at a tertiary care center in North India, including 100 opioid-dependent males (50 NIOUs and 50 IDUs). Sociodemographic, clinical, and psychosocial variables were assessed using structured interviews and validated instruments, including the Maudsley Addiction Profile, the severity of dependence scale (SDS), the high-risk behavior scale (HRBS), the sensation seeking scale (SSS), the Barratt Impulsiveness Scale (BIS), and the WHO-ASSIST. Results: IDUs had significantly higher histories of alcohol use, duration of cannabis use, and family history of substance use, and significantly higher scores on HRBS, BIS, and the SSS ( p < .05). WHO-ASSIST and SDS scores were comparable between the groups. IDUs had a substantially higher number of days of heroin use in the last month and days of conflicts with relatives ( p < .05). Mean duration of the transition period from NIOU to IDU was 4 ± 3.3 years. Conclusions: Family history of drug use, higher sensation seeking, impulsivity, and risk-taking behavior were found to be important factors related to IDU. Interventions targeting these factors are essential for preventing the transition from NIOU to IDU.

  • Motor stereotypies, Dhat syndrome, and gaming disorder: A masquerading presentation of Wilson's disease

    by Raja Babu Ramawat, Omar Afroz, Romil Saini, Koushik Sinha Deb, Divya M Radhakrishnan, Rakesh Kumar Chadda

    Wilson's disease, a rare genetic disorder caused by ATP7B gene mutations, disrupts copper metabolism, often presenting with psychiatric symptoms in 20–30% of cases before diagnosis. Diagnostic challenges arise owing to non-specific symptoms, leading to potential misdiagnosis. Dhat syndrome, a culture-bound syndrome prevalent in the Indian subcontinent, involves distress over perceived semen loss and, thus, the loss of vitality. We report a case of a young male with dhat syndrome, asymmetrical hand movements, behavioural changes, and gaming disorder who, after long being treated for functional neurological disorder, was later diagnosed with Wilson's disease after a comprehensive evaluation.

  • Open Access

    Analyzing the Relationship Between Chronic and Occasional Alcohol Consumption Patterns and Their Association with Attentional Bias: An Eye-tracking Methodology

    by Newfight Seth, Omar Afroz, Raja Babu Ramawat, Apinderjit Kaur, Stuti Karna, Shalini Singh, Roshan Bhad, Rohit Verma, Ravindra Rao

    Background: Alcohol use disorder (AUD) is accompanied by cognitive impairments, including attentional bias towards cues linked to alcohol. Most studies on attentional biases have focused on participants in intoxicated states, with limited research on differences between chronic and occasional users. This study aimed to examine attentional biases in chronic alcohol users compared to occasional users using eye-tracking. Methods: In this cross-sectional study, 71 male participants (36 chronic users and 35 occasional users) were recruited from a tertiary care center in India. Eye-tracking assessments were conducted using free-viewing of emotional and landscape images, and viewing of alcohol related stimuli. For each task, variables such as the number of fixations, fixation duration, scan path, and anti-saccade rates were calculated. Results: No statistically significant difference was found between chronic alcohol users and occasional users in fixation metrics, scan path length, or anti-saccade rates for emotional, landscape, or alcohol related stimuli. Chronic alcohol users had slightly longer fixation durations and greater scan path lengths on alcohol-related stimuli, but these differences were not significant ( p > .05). Conclusions: Our findings suggest that chronic alcohol users may not always display prominent attentional biases in a sober state. The prolonged abstinence duration (>2 months) contributed to the absence of significant biases in our study. The slightly longer scan path length for alcohol-related images among chronic users may indicate that they were possibly avoiding these images. The findings also highlight the need for a state-dependent approach and the importance of assessing variables like craving in future research.


  • Current status of pheniramine misuse among substance use disorder patients: A narrative review of extent, patterns, and clinical implications

    by Raja Babu Ramawat, Omar Afroz, Rizwana Quraishi, Siddharth Sarkar

    Background: There is growing concern about the misuse of Over-the-counter (OTC) medications around the world. Pheniramine is a first-generation antihistamine, which is widely available and is commonly used for allergic conditions. Initially considered to be a safe anti-allergic agent, growing evidence suggests its potential for misuse and dependence. Notably, it is reported that pheniramine is being used to mix other substances such as opioids during injection drug use. However, pheniramine misuse is not adequately studied in existing literature. Objective: This review aims to synthesize the literature on pheniramine misuse, and summarize the published case reports on pheniramine misuse to understand its clinical implications. Methods: A comprehensive literature search was conducted using PubMed, Google Scholar, and MedSearch to identify case reports, epidemiological data, and clinical studies regarding pheniramine misuse. We included articles in English language, published in peer- review journals, and indexed in PubMed. The keywords for the search included ‘Pheniramine use’, ‘misuse’ ‘abuse’, ‘dependence’, ‘harmful use’, ‘substance use disorder’, ‘opioid use disorder’, and ‘injecting drug user’. Results: Pheniramine has misuse potential comparable to Lorazepam. It is often combined with opioids and/or diazepam and used through injection route, commonly in South Asian region. Studies on extent of its use are mainly from South Asia, which report comorbid use of pheniramine ranging from around 15% to 80% in injection drug users. Use of pheniramine is often under-reported by patients. In literature, more than 8 case reports describe the misuse/dependence of pheniramine and associated complications such as seizures, psychosis, and life-threatening toxicity. Easy accessibility might be one of the contributing factors for pheniramine misuse. Conclusion: Pheniramine misuse is an emerging challenge and clinicians should remain vigilant about its signs, especially in those with substance use and psychiatric comorbidities.